Azenta (AZTA) Projected to Release Earnings on Tuesday

Azenta (NASDAQ:AZTA) will likely be announcing its Q3 2026 results before the market opens on Tuesday, August 4th. Analysts expect Azenta to post earnings of $0.1138 per share and revenue of $149.2380 million for the quarter. Investors can find conference call details on the company’s upcoming Q3 2026 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 8:30 AM ET.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings results on Wednesday, May 6th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of $0.12 by ($0.16). Azenta had a positive return on equity of 1.23% and a negative net margin of 30.49%.The business had revenue of $144.79 million during the quarter, compared to analyst estimates of $148.47 million. During the same quarter last year, the firm earned $0.01 EPS. The business’s revenue was up 1.4% on a year-over-year basis.

Azenta Trading Down 2.3%

Azenta stock opened at $28.13 on Friday. The firm has a market capitalization of $1.30 billion, a P/E ratio of -7.10 and a beta of 1.37. Azenta has a twelve month low of $15.93 and a twelve month high of $41.73. The stock’s fifty day simple moving average is $24.68 and its 200-day simple moving average is $25.81.

Institutional Investors Weigh In On Azenta

Hedge funds and other institutional investors have recently modified their holdings of the company. Corient Private Wealth LLC acquired a new position in shares of Azenta during the fourth quarter worth $755,000. Front Street Capital Management Inc. raised its stake in Azenta by 14.1% in the fourth quarter. Front Street Capital Management Inc. now owns 285,252 shares of the company’s stock valued at $9,487,000 after buying an additional 35,270 shares in the last quarter. XTX Topco Ltd raised its stake in Azenta by 298.8% in the fourth quarter. XTX Topco Ltd now owns 68,557 shares of the company’s stock valued at $2,280,000 after buying an additional 51,368 shares in the last quarter. Voloridge Investment Management LLC purchased a new stake in Azenta during the 4th quarter worth about $992,000. Finally, Twinbeech Capital LP purchased a new stake in Azenta during the 4th quarter worth about $329,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts recently commented on AZTA shares. Weiss Ratings raised Azenta from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 15th. Needham & Company LLC reduced their price target on Azenta from $44.00 to $33.00 and set a “buy” rating on the stock in a research report on Wednesday, May 6th. Four equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $40.40.

Azenta Company Profile

Azenta, Inc (NASDAQ: AZTA) is a life sciences technology company specializing in sample management, cryogenic storage and genomic services for research and clinical applications. Formerly the Life Sciences division of Brooks Automation, Azenta provides integrated solutions that enable customers to store, track and analyze biological samples with high levels of automation, data integrity and efficiency. Its offerings span automated storage systems, biorepository management software and end‐to‐end sample tracking workflows.

In addition to hardware and informatics platforms for sample storage, Azenta’s Genomics business delivers next‐generation sequencing (NGS), DNA synthesis, and molecular biology services.